Intravenous diltiazem for perioperative angina pectoris in coronary artery revascularization:Outcome of 128 cases
- VernacularTitle:静滴地尔硫治疗冠脉重建术围手术期心绞痛128例疗效分析
- Author:
Hongyun ZANG
;
Quanmin JING
;
Yaling HAN
- Publication Type:Journal Article
- Keywords:
Coronary artery disease Coronary artery revascularization Angina pectoris Diltiazem
- From:
Chinese Journal of Practical Internal Medicine
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy and safety of intravenous diltiazem in patients with perioperative angina pectoris in coronary artery revascularization.Methods Totally 128 patients with angina pectoris during perioperation of coronary artery revascularization received intravenous diltiazem.The efficacy was determined by angina symptom,changes of blood pressure (BP) and heart rate (HR),and acute heart events after 2 weeks.Results Ninety-one cases had no relapse and 37 were obviously improved of angina symptoms.BP and HR were safely lowered after intravenous diltiazem.Of the 128 cases,85 received successful PCI and were discharged 1-3 weeks postoperatively;41 of 43 cases successfully received CABG;2 died of ventricular fibrillation and heart failure.There was not side-effect in all patients.Conclusion Intravenous diltiazem is effective and safe for with angina pectoris during perioperation of coronary artery revascularization.
